These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. High glutamic acid decarboxylase antibody titers may be associated with a decline in β-cell function over time and future insulin deficiency in latent autoimmune diabetes in adults. Haisa A, Oikawa Y, Satomura A, Suzuki S, Nakanishi S, Fujisawa M, Morita H, Katsuki T, Shimada A. Diabetes Res Clin Pract; 2024 Sep; 215():111799. PubMed ID: 39084295 [Abstract] [Full Text] [Related]
5. Persistence of glutamic acid decarboxylase antibody (GADA) is associated with clinical characteristics of latent autoimmune diabetes in adults: a prospective study with 3-year follow-up. Huang G, Yin M, Xiang Y, Li X, Shen W, Luo S, Lin J, Xie Z, Zheng P, Zhou Z. Diabetes Metab Res Rev; 2016 Sep; 32(6):615-22. PubMed ID: 26787598 [Abstract] [Full Text] [Related]
6. [Vaccine for prevention of type 1 diabetes mellitus]. Surković I, Suljević I, Ascić-Buturović B, Heljić B. Med Arh; 2006 Sep; 60(3):198-9. PubMed ID: 16719238 [Abstract] [Full Text] [Related]
7. Associated autoimmunity in Type 1 Diabetes and latent autoimmune diabetes of adults: The role of glutamic-acid decarboxylase autoantibodies. Gougourelas D, Tsentidis C, Koufadaki AM, Koutsovasilis A, Gougourela E, Karanasios S, Sotiropoulos A, Bousboulas S, Karavanaki KA. Diabetes Res Clin Pract; 2021 May; 175():108847. PubMed ID: 33945840 [Abstract] [Full Text] [Related]
8. Clinical manifestation and islet β-cell function of a subtype of latent autoimmune diabetes in adults (LADA): positive for T cell responses in phenotypic type 2 diabetes. Liang H, Cheng Y, Tang W, Cui Q, Yuan J, Huang G, Yang L, Zhou Z. Acta Diabetol; 2019 Nov; 56(11):1225-1230. PubMed ID: 31367990 [Abstract] [Full Text] [Related]
9. [Features of the development of latent autoimmune diabetes in adults (LADA)]. Timakova AA, Saltykov BB. Arkh Patol; 2019 Nov; 81(4):78-82. PubMed ID: 31407723 [Abstract] [Full Text] [Related]
10. Common autoimmune biomarkers, thyroid hormonal abnormalities, and beta cells dysfunction in patients with latent autoimmune diabetes in adults with type II diabetes mellitus. Yousefzadeh G, Gozashti M, Najafipour H, Gholamhosseinian NA, Bahramnejad A, Shokouhi M. Diabetes Metab Syndr; 2016 Nov; 10(1 Suppl 1):S52-5. PubMed ID: 27094870 [Abstract] [Full Text] [Related]
11. Peripheral blood mononuclear cells of patients with latent autoimmune diabetes secrete higher levels of pro- & anti-inflammatory cytokines compared to those with type-1 diabetes mellitus following in vitro stimulation with β-cell autoantigens. Badal D, Kumar R, Paul M, Dayal D, Bhansali A, Bhadada SK, Kumar R, Sachdeva N. Indian J Med Res; 2017 Jun; 145(6):767-776. PubMed ID: 29067979 [Abstract] [Full Text] [Related]
12. Latent autoimmune diabetes and limbic encephalitis with antibodies against glutamic acid decarboxylase. Popkirov S, Sebastian S, Ismail FS, Wellmer J. J Diabetes; 2018 Apr; 10(4):338-340. PubMed ID: 29154389 [No Abstract] [Full Text] [Related]
13. [Latent autoimmune diabetes of adults (LADA): The informative value of autoantibodies]. Silko YV, Nikonova TV, Ivanova ON, Stepanova SM, Shestakova MV, Dedov II. Ter Arkh; 2016 Apr; 88(10):42-45. PubMed ID: 27801418 [Abstract] [Full Text] [Related]
14. A high titre of autoantibody at onset does not predict pancreatic beta-cell fate. Yanai H. Diabetes Metab; 2016 Dec; 42(6):475-476. PubMed ID: 27502116 [No Abstract] [Full Text] [Related]
15. Evaluation of islet-specific autoantibodies in Japanese patients with insulin-dependent diabetes mellitus: a comparison between autoantibodies to glutamic acid decarboxylase, autoantibodies to 64 kDa islet cell protein and islet cell antibodies. Kawasaki E, Takino H, Yano M, Uotani S, Matsumoto K, Yamaguchi Y, Akazawa S, Nagataki S. J Autoimmun; 1994 Dec; 7(6):791-802. PubMed ID: 7888036 [Abstract] [Full Text] [Related]
16. GADA titer-related risk for organ-specific autoimmunity in LADA subjects subdivided according to gender (NIRAD study 6). Zampetti S, Capizzi M, Spoletini M, Campagna G, Leto G, Cipolloni L, Tiberti C, Bosi E, Falorni A, Buzzetti R, NIRAD Study Group. J Clin Endocrinol Metab; 2012 Oct; 97(10):3759-65. PubMed ID: 22865904 [Abstract] [Full Text] [Related]
17. Beta-cell autoantibodies in children with type 2 diabetes mellitus: subgroup or misclassification? Reinehr T, Schober E, Wiegand S, Thon A, Holl R, DPV-Wiss Study Group. Arch Dis Child; 2006 Jun; 91(6):473-7. PubMed ID: 16449253 [Abstract] [Full Text] [Related]
18. Negativation of type 1 diabetes-associated autoantibodies to glutamic acid decarboxylase and insulin in children treated with oral calcitriol. Papadimitriou DT, Marakaki C, Fretzayas A, Nicolaidou P, Papadimitriou A. J Diabetes; 2013 Sep; 5(3):344-8. PubMed ID: 23302101 [Abstract] [Full Text] [Related]
19. [Auto-antibodies against glutamic acid decarboxylase and diabetes]. Mandrup-Poulsen TR. Ugeskr Laeger; 2007 Jan 22; 169(4):300-4. PubMed ID: 17274923 [Abstract] [Full Text] [Related]
20. Number of autoantibodies and HLA genotype, more than high titers of glutamic acid decarboxylase autoantibodies, predict insulin dependence in latent autoimmune diabetes of adults. Maioli M, Pes GM, Delitala G, Puddu L, Falorni A, Tolu F, Lampis R, Orrù V, Secchi G, Cicalò AM, Floris R, Madau GF, Pilosu RM, Whalen M, Cucca F. Eur J Endocrinol; 2010 Oct 22; 163(4):541-9. PubMed ID: 20603341 [Abstract] [Full Text] [Related] Page: [Next] [New Search]